Bioelectronics Corp (BIEL)

[Boricka]

If it were indeed No. 1 in sales, there is not a legitimate CEO in the world that remove the product from OTC. They would've parlayed that into full distribution at Boots pending the merger with Walgreens. They would then have had a much easier path to distribution at Walgreens. Once this distribution was achieved, assuming success of sales, the other large pharmacies would have been an easy path to full distribution into 20,000 stores. Instead, we are feed this fallacy that Whealan "chose" to take it off the shelf. If he did, he couldn't have been more wrong, as evidence by the sales. Does anyone believe that it is an easier path to have each regional office approve to reimburse, go to a doctor for a prescription, then go to Boots and pick it up? People were going to Boots in the first place, No. 1 in pain sales, correct?

You will reply that it is the reimbursement that is the golden goose. There has been little if any reimbursement to date. Why would that change now? We are left with NO SALES at Boots. All due to the "decision" to take it from OTC, total mis-management of this opportunity!!!

Where is the sales data? Is it too bad to release? Over/under on sales? $200k? That would be less than half of the annual revenue of two years ago, when they were in Boots.